Imunoterapi Sarkoma Dokter Terbaik di Israel - TOP-6 dokter

Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center, berspesialisasi dalam imunoterapi sarkoma dengan pengalaman terfokus lebih dari 25 tahun.

• Anggota fakultas ESMO untuk perawatan sarkoma
• Mendapat pelatihan di Institut Gustave Roussy di Paris – pusat sarkoma terkemuka di Eropa
• Telah menerbitkan publikasi secara ekstensif tentang pendekatan imunoterapi untuk sarkoma langka
• Kepala Klinik Rawat Jalan Onkologi di Sourasky

Dr. Ronit El Hasid telah melakukan lebih dari 300 transplantasi sumsum tulang dan darah tali pusat untuk anak-anak di Rumah Sakit Anak Dana Dwek.

• Kepala Departemen Onkohematologi dan Onkologi Anak (Pediatrik)
• Telah menerbitkan lebih dari 50 makalah dan mempresentasikan lebih dari 40 laporan konferensi
• Anggota American Association for Hematology (Asosiasi Hematologi Amerika)
• Mendapatkan pelatihan di City of Hope Hospital di Los Angeles

Dr. Dror Levin adalah pakar terkemuka dalam imunoterapi sarkoma untuk anak-anak, yang mengkoordinasikan pengobatan di Pusat Medis Sourasky.

• Dokter anak senior di Rumah Sakit Anak 'Dana'
• Direktur departemen hematologi onkologi anak
• Berspesialisasi dalam hematologi dan onkologi pediatrik
• Mempelajari pengobatan sarkoma di Institut Ortopedi Rizzoli di Italia
• Anggota asosiasi hemato-onkologi pediatrik Israel

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Michael Lotem memimpin Pusat Melanoma dan Imunoterapi Kanker di Hadassah Medical Center, merintis imunoterapi baru.

• Berspesialisasi dalam mempelajari reseptor keluarga SLAM untuk respons imun kanker
• Mengarahkan tim klinisi dan peneliti translasi
• Menyediakan akses segera ke data klinis dan jaringan yang berasal dari pasien
• Berfokus pada perawatan inovatif untuk melanoma dan sarkoma